About Synvisc-One
Synvisc-One is a Healthcare company. Pharmaceutical treatments for osteoarthritis knee pain relief. Synvisc-One offers products and services including Synvisc-One and SYNVISC. Its focus areas include Medical Treatments, Osteoarthritis Therapies, Injectable Solutions and Pharmaceuticals. Its legal entity is Sanofi.
Company details
Synvisc-One is developed by Sanofi as a treatment for pain in osteoarthritis of the knee, targeted at patients who have not responded to conservative therapies. It is administered via injection and involves hyaluronan-based products to alleviate symptoms. Safety information is provided to highlight risks such as allergic reactions and infections, emphasizing that it should be used under medical supervision. The product is intended for U.S. residents and focuses on improving knee function without promoting outcomes. Various resources are offered for patients and healthcare professionals to ensure proper use and monitoring.
- SectorsHealthcare
- Phone•••• ••••
- Website synviscone.com
- Social LinkedIn X Facebook YouTube
- Legal Name Sanofi
Products & Services of Synvisc-One
Synvisc-One offers a comprehensive portfolio of products and services, including Synvisc-One and SYNVISC.
A hyaluronan-based injection that is administered for pain relief in osteoarthritis of the knee
A series of injections used for treating knee pain associated with osteoarthritis through hyaluronan therapy
Apps and channels of Synvisc-One
its YouTube channel Sanofi US has 2.18K subscribers and 30 videos.
Videos from Synvisc-One
The most watched videos on Synvisc-One's YouTube channel, Sanofi US (2.18K subscribers). Click a video to play it here.
More on Sanofi US.
Web traffic of Synvisc-One
Websites that share an audience with Synvisc-One (synviscone.com).
Websites whose visitors overlap most with Synvisc-One. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sbfhealthcare.com | 100% | 1.6K | View details | ||
| conformis.com | 82% | 4.6K | #4,233,217 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synvisc-One
Synvisc-One is developed by Sanofi as a treatment for pain in osteoarthritis of the knee, targeted at patients who have not responded to conservative therapies. It is administered via injection and involves hyaluronan-based products to alleviate symptoms. Safety information is provided to highlight risks such as allergic reactions and infections, emphasizing that it should be used under medical supervision. The product is intended for U.S. residents and focuses on improving knee function without promoting outcomes. Various resources are offered for patients and healthcare professionals to ensure proper use and monitoring.
Synvisc-One offers Synvisc-One and SYNVISC.
Synvisc-One operates through Sanofi.